Regulation by long chain fatty acids of the expression of cholesteryl ester transfer protein (CETP) in HepG2 cells by 平野, 玲子 et al.
 1 
Regulation by long chain fatty acids of the expression of cholesteryl ester 
transfer protein (CETP) in HepG2 cells 
 
Reiko Hiranoa,b, Osamu Igarashic, Kazuo Kondoc, Hiroshige Itakurab and 
Akiyo Matsumotob* 
a) Internal Medicine I, National Defense Medical College, Saitama 3598513, 
Japan  
b) Japan National Institute of Health and Nutrition, Shinjuku-Ku, Tokyo 
1628636, Japan 
c) Institute of Environmental Science for Human Life, Ochanomizu 
University, Tokyo 1128612, Japan 
 
Running title: REGULATION BY FATTY ACIDS OF CETP EXPRESSION 
 
Key words: Cholesteryl ester transfer protein; HepG2 cell; Fatty acid; HDL 
metabolism; Gene expression; Northern blot analysis 
 
 2 
FOOT NOTES 
*To whom correspondence should be addressed at Division of Clinical 
Nutrition, National Institute of Health and Nutrition, 1-23-1, Toyama, 
Shinjuku-Ku, Tokyo 1628636 Japan, E-mail; amatsu@nih.go.jp 
 
Abbreviations: AA, arachidonic acid; aLA, α-linolenic acid; BSA, bovine 
serum albumin; C/EBP, CCAAT/enhancer binding protein; CETP, 
cholesteryl ester transfer protein; DgLA, dihomo-γ-linolenic acid; DHA, 
docosahexaenoic acid; DMEM, Dulbecco’s modified Eagle’s medium, ELISA, 
enzyme-linked immunosorbent assay; EPA, eicosapentaenoic acid; FA, fatty 
acid; gLA, γ-linolenic acid; LA, linoleic acid; LCAT, lecithin-cholesterol 
acyltransferase; LPL, lipoprotein lipase; OA, oleic acid; PBS, phosphate 
buffered saline; PUFA, polyunsaturated fatty acid; SA, stearic acid; SDS, 
sodium dodecyl sulphate; SREBP, sterol regulatory element-binding protein, 
SSPE, saline-sodium dihydrogenphosphate-ethylenediamintetraacetate 
buffer 
 3 
ABSTRACT: Cholesteryl ester transfer protein (CETP) is an important 
determinant of lipoprotein function, especially high density lipoprotein 
(HDL) metabolism, and contributes to the regulation of plasma HDL levels. 
Since saturated and polyunsaturated fatty acids (FA) appear to influence 
the CETP activity differently, we decided to investigate the effects of FA on 
the expression of CETP mRNA in HepG2 cells using a RNA blot 
hybridization analysis. Long-chain FA (>18 carbons) at a 0.5 mM 
concentration were added to the medium and incubated with cells for 48 h 
at 37°C under 5% CO2. After treatment with 0.5 mM arachidonic (AA), 
eicosapentaenoic (EPA), and docosahexaenoic acid (DHA), the levels of 
CETP mRNA were less than 50% of the control levels (AA, P = 0.0005; EPA, 
P < 0.01; DHA, P < 0.0001), with a corresponding significant decrease in the 
CETP mass. These results suggest that FA regulate the gene expression of 
CETP in HepG2 and this effect is dependent upon the degree of 
unsaturation of the acyl carbon chain in FA. 
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Cholesteryl ester transfer protein (CETP) is known to be a key protein in 
reverse cholesterol transport. By promoting the transfer and exchange of 
neutral lipids among plasma lipoproteins (1), it determines the plasma 
lipoprotein profile. A CETP deficiency markedly elevates plasma high 
density lipoprotein levels and decreases low density lipoprotein levels (2). 
The normal plasma CETP concentration of normolipidemic subjects ranges 
between 1.1 and 1.7 mg/L (3,4). CETP cDNA clones have been isolated from 
humans, cynomolgus monkeys, rabbits, and hamsters, with about an 
80−95% sequence homology among the species (5−8). In humans, the organs 
with the most abundant expression of CETP mRNA are the liver, spleen, 
and adipose tissue, with lower levels of expression in the small intestine, 
adrenal glands, kidney, and heart (5,6). 
The level of CETP mRNA is responsive to various environmental 
factors (9,10). High-fat and high cholesterol diets (i.e. atherogenic diets) 
have been shown to raise both the mass and mRNA levels of CETP (6,8,11), 
whereas marine lipids, mainly n-3 polyunsaturated fatty acids (PUFA) have 
been shown to reduce plasma cholesterol and triglyceride levels (12) and to 
decrease the CETP mass level in hypercholesterolemic subjects (13). A 
recent study also reported that plasma CETP activity increased in a 
palmitic acid-rich diet in comparison to a stearic acid (SA)-rich diet (14) and 
that dietary trans fatty acids (FA) (e.g. elaidic acid) significantly increased 
the CETP activity in comparison to diets rich in either SA, linoleic acid (LA) 
or palmitic acid (15,16). 
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In vitro studies with CaCo-2 cells (17) and HepG2 cells (18) have 
demonstrated that oleate or butyrate can up-regulate CETP secretion. 
Although the effects of various dietary FA on plasma CETP activity have 
been reported (19,20), whether various types of FA regulate the synthesis or 
expression of CETP mass and/or the mRNA has yet to be explained. 
To elucidate the action of dietary FA on CETP expression, we 
investigated the effects of long-chain FA on the mRNA and protein levels of 
CETP using HepG2 cells as an in vitro model. 
 
MATERIALS AND METHODS 
 
Cell culture. The human hepatoma cell line HepG2 was purchased from the 
Riken gene bank (Wako, Japan), and the cells were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 100 U/mL 
penicillin, 100 µg/mL streptomycin, 265 µg/mL thymidine (all from Life 
Technologies Ltd., Grand Island, NY) and 10% (vol/vol) fetal calf serum 
(Intergen Co., Purchase, NY) at 37°C under 5% CO2. For the experiments 
described herein, the cells were seeded in 60-mm diameter collagen-coated 
culture dishes (Sumitomo Bakelite Co., Ltd., Tokyo, Japan) at a density of 2 
× 105/dish and then were cultured to approximately 90% confluency. 
FA treatments. HepG2 cells were grown to 90% confluency in the 
same medium and then were incubated with 10% (vol/vol) fetal calf 
lipoprotein-deficient serum-DMEM supplemented (or not) with 0.5 mM of 
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FA: SA (18:0), oleic (18:1, OA), LA (18:2), alpha-linolenic (18:3, aLA), 
gamma-linolenic (18:3, gLA), arachidonic (20:4, AA), eicosapentaenoic (20:5, 
EPA) and docosahexaenoic (22:6, DHA) acids, which were dissolved in 10% 
essential FA-free bovine serum albumin (BSA) (all from the Sigma 
Chemical Co., St Louis, MO). Following a 48-h incubation at 37°C, 
cell-conditioned media were collected to determine the CETP mass, and the 
cells were dissolved in a denaturing solution for RNA extraction. 
Northern blot analysis. Total RNA was isolated using an acid 
guanidinium thiocyanate-phenol-chloroform extraction method (21). The 
yield of purified RNA samples was determined by absorbance at 260 nm. 
RNA samples (15 µg per lane) were separated by electrophoresis in 1% 
agarose/5.5% formaldehyde gel containing 0.84 µM ethidium bromide, 
followed by capillary transfer to nylon membranes (Nytran-N, Schleicher & 
Schuell GmbH, Dassel, Germany) that were then cross-linked by exposure 
to ultraviolet light. The membranes were prehybridized (4 to 5 h) at 42°C, 
and then were probed overnight at 42°C with a CETP cDNA fragment 
(365−624 bp) which had been labeled with [α-32P]dCTP (NEN Life Science 
Products, Inc., Boston, MA) using a commercial kit (Random Primer DNA 
Labeling Kit, Takara Co., Otsu, Japan) in 5 × saline-sodium 
dihydrogenphosphate-ethylenediaminteraacetate buffer (SSPE), 5 × 
Denhardt’s, 10% dextran sulfate, 50% deionized formamide, 1% sodium 
dodecyl sulfate (SDS), 0.2 mg/ml of heat-denatured salmon sperm DNA, and 
1 mg/ml of BSA. The blot was washed twice at 42°C and twice further at 
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50°C for 30 min with 2 × saline-sodium citrate buffer (SSC), 0.2% SDS and 
then was exposed to an imaging plate (Fuji Film, Tokyo, Japan). The mRNA 
levels were quantitated by estimating the photostimulated luminescence 
per area of the corresponding band with an imaging analyzer (BAS 2000, 
Fuji Film). The data obtained were normalized for a glyceraldehyde 
phosphate dehydrogenase level. Northern hybridization detected CETP 
mRNA in HepG2 dose dependently (r = 0.977, P < 0.0001) when the total 
RNA per lane varied in mass from 0 to 20 µg. 
Measurement of the CETP mass. The CETP mass secreted by HepG 
2 cells into 4 mL culture medium/60-mm i.d. dish was measured using an 
enzyme-linked immunosorbent assay (ELISA) (22). One milliliter of a 
cultured medium was concentrated to about 100 µL using Microcon-10 
(Amicon, Inc., Beverly, MA), and then the CETP mass of the concentrated 
medium was determined using the CETP (Chugai) ELISA kit (Chugai 
Pharmaceutical Co., Ltd., Tokyo, Japan). The results obtained were then 
adjusted to the original volume. 
Analysis of the FA content in HepG2 cells. The cells were washed 
three times with PBS without Ca2+/Mg2+ before the cell lipids were 
extracted by the method of Folch et al. (23). The lipids were analyzed after 
methylation using HCl-methanol with margaric acid (17:0) as an internal 
standard as described in a previous paper (24). The FA content was then 
measured by gas−liquid chromatography (PerkinElmer Auto System GC, 
Palo Alto, CA) on an Rscot Sillier 5CP capillary column (0.25 mm i.d. × 50 
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m; Nihon Chromato Works Ltd., Tokyo, Japan). The protein concentration of 
the cells was determined with a Micro BCA Protein Assay Reagent kit 
(Pierce Laboratories Inc., Rockford, IL) using BSA as a standard. 
Statistical analysis. The results are presented as the mean ± SE. 
Statistical comparisons of the experimental groups and a linear regression 
analysis were performed using one-way analysis of variance, and each group 
was compared with each other by Fisher’s protected least significant 
difference test. The level of significance was set at P < 0.05. Analyses were 
performed using the StatView J4.51.1 software package (Abacus Concepts 
Inc., Berkeley, CA). 
 
RESULTS 
 
Expression of CETP by FA treatment. To investigate the influence of FA on 
the CETP mRNA levels, HepG2 cells were treated with 0.5 mM of various 
kinds of FA. After 48 h of incubation, both the cell growth and morphology 
were normal in these treatments. Figures 1A and 1B show the effect of 
various FA on the levels of mRNA and protein of CETP in the HepG2 cells, 
respectively. After treatment with 0.5mM of AA, EPA, and DHA, the 
expression of CETP mRNA was less than 50% that of the control (Fig. 1A, P 
< 0.0001). Decreases in the CETP mRNA levels correlated with the 
increases in the degree of unsaturation of FAs. As shown in Fig. 1B, AA, 
EPA, and DHA also induced a significant decrease, relative to the control, in 
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the CETP mass levels that correlated with the expression of CETP mRNA 
(AA, P = 0.0005; EPA, P < 0.01; DHA, P < 0.0001). On the other hand, in the 
presence of 0.5 mM of SA, OA and LA, each of which contains 18 acyl 
carbons, the induction of the CETP mass was facilitated as the degree of 
unsaturation increased (OA vs. SA, P < 0.05; LA vs. SA, P < 0.005), even 
though the mRNA level decreased in these cases. 
Correlation between the CETP protein mass and the mRNA level. 
To analyze the correlation between the CETP mass and the mRNA level, we 
plotted the levels of the CETP mass and mRNA obtained after treatment 
with both the n-6 and n-3 series of FA, respectively (Figs. 2, 3). These plots 
indicated that the n-6 and n-3 series each reduced both the CETP mass and 
mRNA level as the degree of unsaturation increased. The degree of 
unsaturation was strongly related to the expression of CETP if FA were 
classified into two groups consisting of the n-6 and n-3 series. Furthermore, 
the CETP mass and the mRNA levels both showed a positive correlation in 
this experiment (n-6, r = 0.986; n-3, r = 0.998). 
Incorporation and metabolism of FA. As shown in Table 1, each FA 
added to the media increased the cellular FA concentration in comparison to 
the control, which was incubated without FA, thus indicating that FA were 
incorporated into HepG2 after 48 h of incubation. The metabolism of PUFA 
in humans and other animals proceeds by both chain elongation, such as 
biosynthesis of dihomo-γ-linolenic acid (DgLA, 20:3n−6) from gLA (18:3n−6), 
and desaturation, such as biosynthesis of gLA (18:3n−6) from LA (18:2n−6). 
 10 
For example, in the n−9 series, the concentration of OA (18:1n−9) and 
20:3n9, the metabolites of SA (18:0n−9), increased from 639.7 to 1424.9 
nmol/mg protein and from undetectable levels to 78.2 nmol/mg protein after 
48 h of incubation, respectively. In the n−6 series, DgLA and AA (20:4n−6), 
the metabolites of LA, were undetectable but rose to 172.1 nmol/mg protein 
and from 38.0 to 65.2 nmol/mg protein, respectively. Similarly in the n−3 
series, 20:4n−3, the undetectable metabolite of aLA, increased to 203.8 
nmol/mg protein. By the addition of LA, DgLA increased to 172.1 nmol/mg 
protein, while AA rose to a level that was 27.2 nmol/mg protein more than 
the control. Similarly, 20:4n−3 increased to 203.8 nmol/mg protein, while 
EPA (20:5n−3) was not detectable after treatment with aLA. These results 
supported the findings of previous reports in which the low activity of 
∆5-desaturase in HepG2 resulted in the accumulation of DgLA or 20:4n−3 
(24). 
 
DISCUSSION 
 
These studies demonstrate that FA influence both the expression of CETP 
mRNA and protein in HepG2 cells. The human hepatoma-derived cell line 
HepG2 reveals many characteristic differences for normal differentiated 
hepatocytes, and very low levels of CETP gene expression and CETP 
activity in the medium have been reported (18,25,26). In the present study, 
using a northern blot analysis we succeeded in detecting low amounts of 
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radioactivity in bands corresponding to CETP mRNA. 
FA of various chain lengths and degrees of unsaturation have been 
reported to affect the expression of enzymes and proteins involved in lipid 
metabolism (27−31). For example, previous studies reported that long-chain 
FA increase lipoprotein lipase (LPL) mRNA but reduce the degree of LPL 
activity, presumably therefore regulating the posttranslational processing of 
LPL (29). Skretting et al. (30) also found that lecithin-cholesterol 
acyltransferase (LCAT) activities and mRNA levels in HepG2 cells 
decreased due to a posttranscriptional mechanism following sodium 
butyrate treatment. Faust et al. (17) reported that CETP secretion 
measured by the CETP activity was regulated in response to the OA 
concentration in CaCo-2 cells. 
We therefore investigated whether various types of FA, particularly 
those with different degrees of unsaturation, influenced the expression of 
CETP. The results demonstrated that increasing degrees of unsaturation of 
FA reduced the CETP mRNA levels; for example, the expression of the 
CETP mRNA decreased to less than 50% of that of the control with 0.5 mM 
of AA, EPA, or DHA (Fig. 1A). The CETP mass levels also decreased 
significantly based on the levels of CETP mRNA expression. These results 
were also supported by the findings of previous studies, which suggested the 
mRNA level is a major determinant of secreted CETP protein (11,26). The 
increasing FA concentration in HepG2 cells after FA treatments also 
indicated that the FA influenced the expression of CETP mRNA and protein 
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(Table 1). Although the mechanism of regulation of CETP protein secretion 
by FA remains unknown, some interesting findings have appeared. Agellen 
et al. (26) indicated that CCAAT/enhancer binding protein (C/EBP) -α levels 
influence CETP mRNA expression, since C/EBP-α binds to the site of CETP 
gene promoter and activates the CETP promoter activity. Raclot et al. (27) 
found that C/EBP-α mRNA level is influenced by PUFA in the following 
order: DHA-rich diets > EPA-rich diets > OA-rich diets. Our observations 
are in accord with this finding, which may, in part, suggest that the 
mechanisms for the modulation of the mRNA levels by PUFA occur 
indirectly through the expression levels of C/EBP because the 
transcriptional levels of CETP are partly dependent on C/EBP. Ritsch A et 
al. (32), however, reported that C/EBP had no specific influence on the 
expression of CETP in HepG2. Another possible mechanism for the 
regulation of the CETP gene expression by FA may be the influence of 
apolipoprotein regulatory protein-1 (ARP-1) and/or v-erbA-related protein-3 
(Ear-3)/chicken ovalbumin upstream promoter transcription factor 
(COUP-TF) (33), which are orphan receptors, and sterol regulatory 
element-binding proteins (SREBP) (34,35). These transcriptional factors, 
especially SREBP-1 (34,35), play an important role in controlling CETP 
gene expression. Kim et al. (36) described how SREBP-1 expression in the 
liver nuclei of fish oil-fed mice decreased by 57% compared with safflower 
oil-fed mice. Yahagi et al. (37) reported that dietary PUFA drastically 
decreased the mature, cleaved form of SREBP-1 protein in the nucleus in 
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the liver of wild-type mice, presumably due to the reduced cleavage of the 
SREBP-1 precursor protein. Therefore, the regulation of the CETP gene 
expression by FA may be mediated by the cooperative interaction with 
SREBP-1 and other transcriptional factors. 
On the other hand, the concentration of FA in lipoprotein particles 
influences the CETP-mediated cholesteryl ester transfer activity in vitro 
(20,38,39); that is, a low concentration of FA stimulates and promotes CETP 
activity while increasing the FA concentrations above an optimal level, thus 
inhibiting the CETP activity in a dose-dependent manner. Both the length 
and degree of unsaturation of the FA acyl carbon chain also affect the CETP 
activity. The CETP activity is thus likely to be influenced by double bonds 
in the trans instead of the natural cis configuration (15,16); however, we did 
not investigate the effects of trans fatty acids on the gene expression of 
CETP. Further studies are needed to reveal whether a different 
configuration (cis- or trans-) of FA possibly controls the expression of CETP 
mRNA. 
Our present data indicate that FA regulate gene expression of CETP 
in HepG2, and this effect is dependent upon the degree of unsaturation of 
the acyl carbon chain in FA. FA may therefore be convenient modulators of 
both the CETP expression level and the cholesteryl ester transfer activity. 
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LEGENDS 
 
Fig. 1 Comparative effects of various saturated and unsaturated fatty 
acids on the expression of the cholesteryl ester transfer protein (CETP) 
mRNA (A) and mass (B). HepG2 cells were incubated with 0.5 mM of 
various fatty acids or 1.25% bovine serum albumin (as a control) for 48 h in 
Dulbecco’s Modified Eagle’s Medium with 10% lipoprotein deficient serum. 
The CETP mRNA and mass were measured as described in the text. Each 
data point represents the mean ± SE from three dishes. In A, statistical 
differences are shown as ** P < 0.005, *** P < 0.0001 relative to the control, 
and in B * P < 0.05, ** p < 0.01, *** P = 0.0005, **** P < 0.0001 and in both 
a p < 0.05, b p < 0.005 relative to stearic acid (SA). OA, oleic acid; LA, linoleic 
acid; aLA, α-linolenic acid; gLA, γ-linolenic acid; AA, arachidonic acid; EPA, 
eicosapentaenoic acid; DHA, docosahexaenoic acid. 
 
Fig. 2 Relationship between the CETP mRNA and mass secreted into the 
medium after the treatment of n-6 fatty acids. A linear regression analysis 
demonstrates a positive correlation between CETP mRNA and mass (r = 
0.986). Each data point represents the mean ± SE from three dishes. For 
abbreviations see Figure 1. 
 
Fig. 3 Relationship between the CETP mRNA and mass secreted into the 
medium after the treatment of n-3 fatty acids. A linear regression analysis 
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demonstrates a positive correlation between CETP mRNA and mass (r = 
0.998). Each data point represents the mean ± SE from three dishes. For 
abbreviations see Figure 1. 
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TABLE  1 
The composition of PUFA in HepG2 cells 
Added PUFAs 18:0 18:1n9 18:2n6 18:3n3 20:3n9 20:3n6 20:4n6 20:4n3 20:5n3 22:4n6 22:6n3 
Control 128.9±15.5 639.7±86.7 14.2±1.9 nd nd nd 38.0±4.9 nd nd nd nd 
18:0 540.4±34.1e 1424.9±73.6d 9.6±4.9 nd 78.2±4.3 nd 46.7±2.5 nd nd nd nd 
18:1n9 131.9±23.0 1738.4±281.6e 9.85±.5 nd 88.8±14.5 nd 34.9±5.5 nd nd nd nd 
18:2n6 216.4±29.4a 502.0±68.4 1275.4±154.2e nd nd 172.1±21.2 65.2±9.4b nd nd nd nd 
18:3n3 179.0±7.6 446.7±18.8 14.3±0.8 1115.3±50.5 nd nd 34.7±1.3 203.8±6.5 nd nd nd 
20:4n6 153.1±2.3 228.9±5.9a 7.1±1.2 nd nd nd 633.1±12.2e nd nd 226.1±9.8 nd 
20:5n3 234.9±9.6c 422.9±19.0 15.0±3.2 nd nd nd 42.8±1.7 nd 619.7±42.7 nd 513.7±37.5 
22:6n3 148.4±26.9 352.9±63.6 11.5±1.7 nd nd nd 28.9±4.9 nd 9.4±5.9 nd 911.0±146.4 
Note.  Data are expressed as nmol/mg cell protein and are the means ± SE from 3 dishes.  nd, not detectable.  a ; p<0.05, b ; p<0.01, c ; p<0.005, d ; 
p<0.0005, e ; p<0.0001 ; significantly different from the control according to the ANOVA and Fisher’s PLSD test. 
